An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Genetic testing, including germline and somatic, is vital for prostate cancer prognosis and personalized treatment strategies. PARP inhibitors, targeting BRCA mutations, are a promising therapy for ...

Older men with prostate cancer who receive federal housing assistance at the time they are first diagnosed have better ...

Prostate cancer is a common cancer in men that begins in the prostate gland, a key part of the male reproductive system. Early stages often grow slowly and show few or no symptoms, making detection ...

ADT intensification may not improve prostate cancer survival. Explore real-world findings and key risk factors. Read more.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...